These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34505178)

  • 21. Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
    Cui L; He T; Jiang Y; Li M; Wang O; Jiajue R; Chi Y; Xu Q; Xing X; Xia W
    Osteoporos Int; 2020 Feb; 31(2):307-316. PubMed ID: 31754756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
    Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
    Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hip fracture trends in the United States, 2002 to 2015.
    Lewiecki EM; Wright NC; Curtis JR; Siris E; Gagel RF; Saag KG; Singer AJ; Steven PM; Adler RA
    Osteoporos Int; 2018 Mar; 29(3):717-722. PubMed ID: 29282482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic implications of osteoporotic fractures in postmenopausal women.
    Patel J
    Am J Manag Care; 2020 Nov; 26(15 Suppl):S311-S318. PubMed ID: 33263967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Osteoporos Int; 2011 Aug; 22(8):2347-55. PubMed ID: 21287148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Si L; Winzenberg TM; Jiang Q; Palmer AJ
    Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm.
    Kim K; Svedbom A; Luo X; Sutradhar S; Kanis JA
    Osteoporos Int; 2014 Jan; 25(1):325-37. PubMed ID: 24114398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender Disparities in Osteoporosis Screening and Management Among Older Adults.
    Ramachandran S; Williams SA; Weiss RJ; Wang Y; Zhang Y; Nsiah I; Bhattacharya K
    Adv Ther; 2021 Jul; 38(7):3872-3887. PubMed ID: 34053012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
    Wang Z; Ward MM; Chan L; Bhattacharyya T
    Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
    Ioannidis G; Flahive J; Pickard L; Papaioannou A; Chapurlat RD; Saag KG; Silverman S; Anderson FA; Gehlbach SH; Hooven FH; Boonen S; Compston JE; Cooper C; Díez-Perez A; Greenspan SL; Lacroix AZ; Lindsay R; Netelenbos JC; Pfeilschifter J; Rossini M; Roux C; Sambrook PN; Siris ES; Watts NB; Adachi JD;
    Osteoporos Int; 2013 Jan; 24(1):59-67. PubMed ID: 22525976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China.
    Wu J; Qu Y; Wang K; Chen Y
    Value Health Reg Issues; 2019 May; 18():106-111. PubMed ID: 30909083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.
    Kim SC; Kim MS; Sanfélix-Gimeno G; Song HJ; Liu J; Hurtado I; Peiró S; Lee J; Choi NK; Park BJ; Avorn J
    Am J Med; 2015 May; 128(5):519-26.e1. PubMed ID: 25660252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Economic Burden of Severe Osteoporotic Fractures in the French Healthcare Database: The FRACTOS Study.
    Thomas T; Tubach F; Bizouard G; Crochard A; Maurel F; Perrin L; Collin C; Roux C; Paccou J
    J Bone Miner Res; 2022 Oct; 37(10):1811-1822. PubMed ID: 36203366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Mori T; Crandall CJ; Ganz DA
    Osteoporos Int; 2017 May; 28(5):1733-1744. PubMed ID: 28210776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
    Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
    Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
    Han S; Kim S; Yeh EJ; Suh HS
    Osteoporos Int; 2024 Feb; 35(2):339-352. PubMed ID: 37878064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data.
    Hadji P; Schweikert B; Kloppmann E; Gille P; Joeres L; Toth E; Möckel L; Glüer CC
    Arch Gynecol Obstet; 2021 Sep; 304(3):703-712. PubMed ID: 34247254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
    Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
    Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.